On the immune side, 5-HT1A receptors expressed on T cells promote the expansion of CD4(+)CD25(+)Foxp3(+) regulatory T cells while lowering the Th1/Th2 ratio, whereas on tumor cells, 5-HT1A receptor activity negatively correlates with cytotoxic lymphocyte function. Here, HTR1A is linked to neoplasm.